FR EN MAIN NAVIGATION COMPANY SCIENCE PRODUCTS PARTNERING INVESTORS MEDIA CAREERS CLINICAL TRIALS Home Products Clinical trials Our commitment to patients Innate Pharma is advancing an innovative pipeline of antibody-based therapeutics by leveraging the body’s immune system to improve outcomes for patients suffering from cancer and other life-threatening diseases. At Innate Pharma, we believe the immune system plays a critical role in many diseases and offers unique opportunities to find meaningful solutions for patients with complex and underserved diseases. We are committed to converting groundbreaking scientific insights in immune biology into new immunotherapies that improve patient outcomes, extend lives and offer new hope for those patients who have no other options. We are committed to advance immunotherapeutic breakthroughs by applying the highest level of scientific standards and develop effective and safe innovative treatments for patients. Our clinical trials currently enrolling patients Information about ongoing clinical trials for Innate Pharma’s investigational drugs is available at clinicaltrials.gov, a service of the U.S. National Institutes of Health that provides details on clinical trials conducted worldwide. Currently active clinical trials with our product candidates. Oncology Indication Product Phase Trial Sponsor Advanced T cell lymphoma (Sézary syndrome and Mycosis fungoides) Lacutamab Phase 2 TELLOMAK Innate Pharma Learn more Relapse/Metastatic Squamous Cell Carcinoma of the Head and Neck Monalizumab Phase 3 INTERLINK-1 AstraZeneca Learn more Relapse/Metastatic Squamous Cell Carcinoma of the Head and Neck Monalizumab Phase 1b/2 IPH2201-203 Innate Pharma Learn more Relapse/Metastatic Squamous Cell Carcinoma of the Head and Neck* Monalizumab Phase 2 UPSTREAM EORTC Learn more Advanced Solid Tumors, including Colorectal Cancer Monalizumab Phase 1/2 D419NC00001 AstraZeneca Learn more Unresectable Stage III Non Small Cell Lung Cancer Monalizumab Phase 2 COAST AstraZeneca Learn more Resectable Early Stage Non Small Cell Lung Cancer Monalizumab Phase 2 NeoCOAST AstraZeneca Learn more Non Small Cell Lung Cancer with PD-1 Resistance* Monalizumab Phase 2 PIONeeR AP-HM Learn more Post-Allogenic Stem Cell Transplantation* Monalizumab Phase 1 PIRAT Institut Paoli-Calmettes Learn more Advanced Solid Tumors IPH5201 Phase 1 NA AstraZeneca Learn more Non-oncology Indication Product Phase Trial Sponsor Bullous Pemphigoid* Avdoralimab Phase 2 NA Centre hospitalier de Nice Learn more COVID-19 with severe pneumonia* Avdoralimab Phase 2 FORCE AP-HM Learn more Advanced or Metastatic Cancer and COVID-19 Avdoralimab Monalizumab Phase 2 IMMUNONCOVID Centre Léon Bérard Learn more *IST: investigator sponsored trials Clinical trials Clinical trials are a major component of drug development to ensure both safety and efficacy of a particular drug candidate. All potential medicines go through a rigorous series of clinical trials before it can be approved by regulatory authorities and marketed. FAQ What are clinical trials? What are the different phases of clinical trials? What are the benefits and risks of clinical trials? Who can participate in a clinical trial and how? Patient resources More information and additional resources on specific diseases, can be found at the links below: Institut National du Cancer (France) – www.e-cancer.fr National Institutes of Health – National Cancer Institute (USA) – www.cancer.gov American Cancer Society – www.cancer.org Cutaneous Lymphoma foundation – www.clfoundation.org Hairy Cell Leukemia Foundation – www.hairycellleukemia.org Main menu Pipeline overview Clinical trials ------------------ Lacutamab Monalizumab Avdoralimab IPH5201 IPH5301 IPH6101 IPH62 Footer Contact Location Legal Info Terms of use Privacy Notice Cookies notice General Conditions of Purchase Search Search Follow us Stay in touch Subscribe to our newsletter Contact us Location 117, Avenue de Luminy - BP 30191 13 009 Marseille FRANCE +33 (0)4 30 30 30 30 Innate Pharma, Inc. 2273 Research Boulevard, Suite 350 Rockville, MD 20850, USA